Search

Displaying results 7481 - 7490 of 10000 in total
  1. Drug

    Vecabrutinib

    go.drugbank.com/drugs/DB16657
    Investigational

    Vecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers).

  2. Drug

    Mycobacterium w. Vaccine

    go.drugbank.com/drugs/DB15798
    Investigational

    As an immunotherapy, M.w is used against leprosy; the compound also shares antigens with M. tuberculosis. … As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.

  3. Drug

    Bacillus calmette-guerin substrain tokyo 172-1 live antigen

    go.drugbank.com/drugs/DB14968
    Investigational

    Bacillus calmette-guerin substrain tokyo 172-1 live antigen is under investigation in clinical trial NCT03091660 (S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive

  4. Drug

    Retatrutide

    go.drugbank.com/drugs/DB18993
    Investigational

    Retatrutide is under investigation in clinical trial NCT06354660 (Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise

    Products: RETATRUTIDE Pen
  5. Drug

    Modimelanotide

    go.drugbank.com/drugs/DB15314
    Investigational

    Modimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing

  6. Drug

    Nesvacumab

    go.drugbank.com/drugs/DB15330
    Investigational

    Nesvacumab is under investigation in clinical trial NCT01997164 (Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (Wet) Age Related Macular Degeneration (AMD) or

  7. Drug

    MORF-057

    go.drugbank.com/drugs/DB23674
    Investigational

    MORF-057 is under investigation in clinical trial NCT06226883 (A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease).

  8. Drug

    SHR-1179

    go.drugbank.com/drugs/DB33981
    Experimental

    SHR-1179 is under investigation in clinical trial NCT07826364 (A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With Obesity).

  9. Drug

    SB 11285

    go.drugbank.com/drugs/DB17511
    Investigational

    [L45123] SB 11285 is under investigation in clinical trial NCT04096638 (Evaluating Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors).

  10. Drug

    FF-10501-01

    go.drugbank.com/drugs/DB17554
    Investigational

    [A257306] FF-10501-01 is under investigation in clinical trial NCT03486353 (A Study of FF-10501-01 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome).